FOLH1 and cancer: In order to identify novel markers for personalized risk stratification, this retrospective multicenter study aims to evaluate the impact of PSMA-PET-guided CT-based radiomic features (RF) derived from PSMA-PET/CT scans on BCR-free survival (BRFS) in patients who receive sRT due to recurrent or persistent PCa cancer after RPE.